Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

IMMX | Immix Biopharma Inc

Index- P/E- EPS (ttm)-0.81 Insider Own74.19% Shs Outstand13.23M Perf Week-0.61%
Market Cap53.17M Forward P/E- EPS next Y-0.84 Insider Trans1.22% Shs Float4.20M Perf Month61.88%
Income-11.39M PEG- EPS next Q-0.23 Inst Own3.91% Short Float / Ratio2.57% / 0.77 Perf Quarter34.02%
Sales0.00M P/S- EPS this Y-36.81% Inst Trans36.31% Short Interest0.11M Perf Half Y75.81%
Book/sh0.81 P/B4.02 EPS next Y-6.36% ROA-65.74% Target Price11.00 Perf Year121.69%
Cash/sh0.78 P/C4.20 EPS next 5Y- ROE-72.70% 52W Range0.68 - 3.65 Perf YTD42.79%
Dividend- P/FCF- EPS past 5Y- ROI-86.12% 52W High-10.41% Beta-0.10
Dividend %- Quick Ratio6.47 Sales past 5Y0.00% Gross Margin- 52W Low380.88% ATR0.35
Employees11 Current Ratio6.47 Sales Q/Q- Oper. Margin0.00% RSI (14)62.50 Volatility17.73% 13.38%
OptionableNo Debt/Eq0.00 EPS Q/Q-111.19% Profit Margin- Rel Volume1.05 Prev Close2.96
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume140.51K Price3.27
Recom1.00 SMA2024.19% SMA5046.41% SMA20051.34% Volume148,024 Change10.47%
Sep-22-23 12:04PM
Sep-21-23 08:55AM
Sep-19-23 09:10AM
Sep-15-23 01:18PM
Sep-07-23 10:38AM
08:41AM Loading…
Sep-01-23 08:39AM
Aug-23-23 08:37AM
Aug-18-23 09:20AM
Aug-16-23 09:05AM
Jul-25-23 08:42AM
Jul-17-23 09:37AM
Jul-10-23 09:47AM
Jun-26-23 09:49AM
Jun-22-23 09:53AM
09:45AM Loading…
Jun-20-23 09:45AM
Jun-16-23 09:43AM
Jun-14-23 07:30AM
Jun-12-23 09:49AM
May-26-23 09:53AM
May-22-23 01:48PM
May-21-23 04:05PM
May-04-23 12:30PM
May-03-23 04:42PM
Apr-26-23 05:30PM
Apr-04-23 08:00AM
Mar-31-23 08:00AM
08:00AM Loading…
Mar-23-23 08:00AM
Mar-10-23 07:45PM
Mar-06-23 08:00AM
Feb-27-23 08:45AM
Feb-15-23 08:30AM
Feb-09-23 08:00AM
Feb-07-23 08:00AM
Jan-13-23 08:00AM
Jan-06-23 08:00AM
Dec-28-22 08:00AM
Dec-20-22 08:00AM
Dec-19-22 08:00AM
Dec-14-22 12:43PM
Dec-13-22 08:00AM
Dec-12-22 08:00AM
Nov-11-22 08:00AM
Oct-25-22 08:00AM
Oct-18-22 08:00AM
Sep-07-22 12:05PM
Aug-23-22 06:36AM
Aug-01-22 10:10AM
May-21-22 08:26AM
May-20-22 10:19AM
May-09-22 08:00AM
Apr-05-22 09:30AM
Mar-16-22 10:13AM
Mar-07-22 08:00AM
Feb-22-22 08:00AM
Feb-01-22 11:36AM
Jan-31-22 08:00AM
Jan-25-22 12:17PM
Jan-19-22 08:00AM
Jan-12-22 08:43AM
Jan-06-22 09:00AM
Jan-03-22 10:46AM
Dec-20-21 04:16PM
Dec-16-21 05:54PM
Dec-15-21 06:00PM
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hsu JasonDirectorSep 15Buy2.497,00017,396757,000Sep 18 07:03 PM
Hsu JasonDirectorSep 14Buy2.5810,00025,772750,000Sep 18 07:03 PM
Ng CareyDirectorSep 14Buy2.5810,00025,76010,000Sep 15 06:27 PM
Hsu JasonDirectorSep 12Buy2.8330,00084,864740,000Sep 18 07:03 PM
Adams Helen C.DirectorSep 12Buy2.9613,00038,49213,000Sep 14 05:20 PM
Hsu JasonDirectorSep 11Buy2.8925,00072,280710,000Sep 18 07:03 PM
Hsu JasonDirectorSep 08Buy2.5310,00025,317685,000Sep 12 04:58 PM
BUCHAN MELISSA JANEDirectorSep 07Buy2.4620,00049,22620,000Sep 11 05:18 PM
Marquet MagdaDirectorSep 06Buy2.479,00022,21320,000Sep 08 05:46 PM
Marquet MagdaDirectorSep 05Buy2.4710,00024,72211,000Sep 06 04:33 PM
Marquet MagdaDirectorAug 31Buy2.011,0002,0101,000Sep 05 06:43 PM
Rachman Ilya MCEO and ChairmanNov 14Buy1.005,2005,225907,700Nov 15 05:33 PM
Morris Gabriel SCFONov 14Buy0.945,2004,88881,316Nov 15 05:31 PM